Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2014-06-12

FDA Approved: HEPARIN SODIUM — Original Application (Sandoz Inc.)

View source ↗

Summary

FDA approved Sandoz Inc.'s original application for generic heparin sodium, an injectable anticoagulant used to prevent and treat thrombotic disorders.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • HEPARIN SODIUM (HEPARIN SODIUM)

Snippet

ORIG AP for HEPARIN SODIUM (HEPARIN SODIUM)